Get the Stockscreener App
19.98
1.16%
0.23
After Hours:
20.05
0.07
+0.35%
Immunome Inc Stock (IMNM) Forecast
The Immunome Inc (IMNM) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.8179, representing a -80.89% decrease from the current price of $19.98. The highest analyst price target is $4.7433, and the lowest is $2.8926.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IMNM Price Target
Average 4.9694
(-75.13% Downside)
Is Immunome Inc (IMNM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.05 | Neutral |
| STOCH(9,6) | 34.27 | Neutral |
| STOCHRSI(14) | 10.72 | Buy |
| MACD(12,26) | 0.4457 | Sell |
| ADX(14) | 23.53 | Neutral |
| William %R | -75.44 | Neutral |
| CCI(14) | -81.46 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
21.03
Sell
|
20.61
Sell
|
| MA20 |
20.90
Sell
|
20.48
Sell
|
| MA50 |
18.81
Buy
|
18.80
Buy
|
| MA100 |
15.23
Buy
|
16.36
Buy
|
| MA200 |
11.96
Buy
|
14.16
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, IMNM could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 5 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on IMNM, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 49.05 indicates that IMNM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 34.27 indicates that IMNM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.72 indicates that IMNM is oversold. This suggests that IMNM price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.53 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -81.46 indicates that IMNM is still oversold but not to an extreme extent.
Long-term IMNM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Immunome Inc financial reports and earnings history, Immunome Inc (IMNM) stock could reach $7.6232 by 2030, $16.53 by 2040 and $12.52 by 2050. See the projected annual prices until 2050 of the Immunome Inc stock below:
- Immunome Inc (IMNM) is expected to reach an average price of $6.9388 in 2035, with a high prediction of $8.2169 and a low estimate of $6.4782. This indicates an $-65.27% rise from the last recorded price of $19.98.
- Immunome Inc (IMNM) stock is projected to chart a bullish course in 2040, with an average price target of $16.45, representing an $-17.65% surge from its current level. The forecast ranges from a conservative $10.77 to a sky-high $16.53.
- Our analysts predict Immunome Inc (IMNM) to jump 33.73% by 2045, soaring from $26.24 to an average price of $26.72, potentially reaching $37.19. While $26.24 is the low estimate, the potential upside is significant.
- Immunome Inc (IMNM) stock is expected to climb by 2050, reaching an average of $11.26, a $-43.67% jump from its current level. However, a wide range of estimates exists, with high and low targets of $12.52 and $9.3976, respectively, highlighting the market's uncertainty.
Immunome Inc Stock (IMNM) Year by Year Forecast
Immunome Inc Stock (IMNM) Price Forecast for 2026
The predicted value for Immunome Inc (IMNM) in 2026 is set at an average of $4.9694. Estimates vary from a peak of $7.0462 to a trough of $2.8926, indicating an -75.13% surge from the present price of $19.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2026 | $4.6933 | $2.8926 | $4.7433 | -76.51% |
| March, 2026 | $3.7541 | $3.3139 | $5.1836 | -81.21% |
| April, 2026 | $4.9002 | $3.3843 | $5.2952 | -75.47% |
| May, 2026 | $6.056 | $4.3555 | $6.606 | -69.69% |
| June, 2026 | $6.1568 | $5.3768 | $7.0462 | -69.19% |
| July, 2026 | $5.5679 | $4.8275 | $6.7374 | -72.13% |
| August, 2026 | $4.9887 | $4.6687 | $5.8881 | -75.03% |
| September, 2026 | $5.2098 | $3.8191 | $5.8625 | -73.93% |
| October, 2026 | $3.0206 | $3.0106 | $5.51 | -84.88% |
| November, 2026 | $6.0815 | $3.2108 | $6.8108 | -69.56% |
| December, 2026 | $5.6925 | $5.3119 | $6.5923 | -71.51% |
Immunome Inc Stock (IMNM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Immunome Inc (IMNM) is $9.4581, with a high forecast of $14.06 and a low forecast of $4.8527. This indicates an -52.66% decrease from the last price of $19.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.5033 | $4.8527 | $6.5033 | -67.45% |
| February, 2027 | $5.6342 | $5.2572 | $6.6036 | -71.80% |
| March, 2027 | $6.3802 | $5.2548 | $8.2352 | -68.07% |
| April, 2027 | $5.6561 | $5.3161 | $6.8005 | -71.69% |
| May, 2027 | $9.7869 | $5.5763 | $10.06 | -51.02% |
| June, 2027 | $8.088 | $7.5347 | $9.8171 | -59.52% |
| July, 2027 | $7.2688 | $6.9588 | $8.3705 | -63.62% |
| August, 2027 | $8.0547 | $6.9492 | $8.7694 | -59.69% |
| September, 2027 | $9.5507 | $7.62 | $10.35 | -52.20% |
| October, 2027 | $8.8115 | $8.6213 | $9.8813 | -55.90% |
| November, 2027 | $8.5524 | $8.137 | $9.0718 | -57.20% |
| December, 2027 | $13.98 | $7.7526 | $14.06 | -30.01% |
Immunome Inc Stock (IMNM) Price Forecast for 2028
In 2028, Immunome Inc (IMNM) is projected to reach an average price of $38.10, with a high projection of $65.35 and a low estimate of $10.85. This indicates an +90.70% rise from the last price of $19.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $17.11 | $13.38 | $20.31 | -14.34% |
| February, 2028 | $25.03 | $16.92 | $28.64 | +25.25% |
| March, 2028 | $25.51 | $22.43 | $31.78 | +27.66% |
| April, 2028 | $14.56 | $14.53 | $25.69 | -27.14% |
| May, 2028 | $12.92 | $11.75 | $16.13 | -35.35% |
| June, 2028 | $12.52 | $11.67 | $13.80 | -37.34% |
| July, 2028 | $11.65 | $11.53 | $15.56 | -41.69% |
| August, 2028 | $16.25 | $10.85 | $16.94 | -18.65% |
| September, 2028 | $39.57 | $15.66 | $65.35 | +98.07% |
| October, 2028 | $37.64 | $27.15 | $50.28 | +88.37% |
| November, 2028 | $25.64 | $24.74 | $43.23 | +28.32% |
| December, 2028 | $19.72 | $17.88 | $34.03 | -1.30% |
Immunome Inc Stock (IMNM) Price Forecast for 2029
The 2029 price forecast for Immunome Inc Stock (IMNM) is $17.39 on average, with a high prediction of $29.39 and a low estimate of $5.3939. This represents an -12.96% decrease from the previous price of $19.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $18.10 | $17.81 | $25.15 | -9.40% |
| February, 2029 | $18.88 | $16.99 | $20.24 | -5.48% |
| March, 2029 | $17.46 | $15.84 | $26.55 | -12.63% |
| April, 2029 | $15.62 | $14.07 | $17.78 | -21.83% |
| May, 2029 | $25.93 | $15.34 | $29.39 | +29.78% |
| June, 2029 | $20.92 | $18.74 | $26.12 | +4.71% |
| July, 2029 | $18.79 | $17.67 | $25.32 | -5.94% |
| August, 2029 | $17.96 | $15.65 | $21.24 | -10.13% |
| September, 2029 | $12.27 | $11.74 | $18.23 | -38.60% |
| October, 2029 | $9.589 | $8.7848 | $11.90 | -52.01% |
| November, 2029 | $6.8606 | $6.8606 | $10.17 | -65.66% |
| December, 2029 | $7.2823 | $5.3939 | $8.0023 | -63.55% |
Immunome Inc Stock (IMNM) Price Forecast for 2030
Immunome Inc Stock (IMNM) is expected to reach an average price of $5.7738 in 2030, with a high forecast of $7.8524 and a low forecast of $3.6953. This signifies an -71.10% decrease from the last price of $19.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.3644 | $4.4144 | $7.6232 | -73.15% |
| February, 2030 | $5.0261 | $3.6953 | $5.6048 | -74.84% |
| March, 2030 | $4.1478 | $4.1178 | $5.9873 | -79.24% |
| April, 2030 | $5.7995 | $4.1886 | $5.8595 | -70.97% |
| May, 2030 | $6.9716 | $5.1608 | $7.3059 | -65.11% |
| June, 2030 | $6.9132 | $6.2324 | $7.8524 | -65.40% |
| July, 2030 | $5.9853 | $5.6349 | $7.5445 | -70.04% |
| August, 2030 | $5.977 | $5.8066 | $6.7458 | -70.08% |
| September, 2030 | $5.4187 | $4.6283 | $6.6579 | -72.88% |
| October, 2030 | $4.7708 | $4.6908 | $6.6723 | -76.12% |
| November, 2030 | $6.7525 | $3.8212 | $7.6217 | -66.20% |
| December, 2030 | $7.0942 | $6.1238 | $7.2032 | -64.49% |
28.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):